Endoscopic Scoring System Utilization in Inflammatory Bowel Disease
- Conditions
- Inflammatory Bowel Diseases
- Registration Number
- NCT05576402
- Lead Sponsor
- Centro de Educación Medica e Investigaciones Clínicas Norberto Quirno
- Brief Summary
Inflammatory bowel diseases comprise two distinctive entities: Crohn's disease and ulcerative colitis. During the last decade, endoscopic assessment of inflammation has become relevant since it is a prognostic factor. As a consequence, therapeutic targets now contemplate mucosal healing as part of the goals to be achieved. Endoscopic scores for Crohn's disease and ulcerative colitis have been developed to objectively assess the mucosal inflammatory activity. Although they may have some limitations, these scores have been widely accepted in referral centers, especially since they have been adopted as standard evaluation in inflammatory bowel disease clinical trials . However, their use in the setting of endoscopic practice outside centers with a high volume or with less experience in clinical trials is not known.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 1500
- Adult patients who underwent colonoscopy for the evaluation of mucosal inflammatory activity
- Patients with an established diagnosis of either Crohn's disease or ulcerative colitis
- Sigmoidoscopies performed in ulcerative colitis for the assessment of mucosal inflammatory activity
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Endoscopic score report January 2018-October 2022 Proportion of colonoscopy reports among inflammatory bowel disease patients which include an endoscopic score to assess inflammatory activity
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
CEMIC
🇦🇷Buenos Aires, Argentina